To access all features of this site, you must enable Javascript. Here are the instructions for enabling Javascript in your web browser.
To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
All the news of the Institute of life sciences Frédéric Joliot
People afflicted with microcephaly have undersized brains. Researchers from the CEA-I2BM have developed a mathematical analysis of MRI images that can discriminate variations in cortical folding complexity. This is a methodological step towards a more effective diagnostic approach, as well as a better understanding of cerebral development.
Why are we not aware of external noises while we sleep? A study by the CEA-I2BM shows that even if the sounds still penetrate into the auditory cortex, sleep disrupts the brain’s ability to anticipate.
A nano-drug has been developed for treating certain neurological diseases such as brain ischemia, as well as injuries to bone marrow. It is composed of a therapeutic molecule, adenosine, and the vector squalene, which allows it to circulate in the body and reach the areas to be treated.
The CEA-IBEB has partnered with the CEA-I2BM to develop original MRI contrast agents. Nano-magnets produced by bacteria may reveal targets at the molecular level.
In this study, we examined whether the JAK/STAT3 pathway promotes astrocyte reactivity in several animal models of ND. The JAK/STAT3 pathway was activated in reactive astrocytes in two transgenic mouse models of Alzheimer's disease and in a mouse and a nonhuman primate lentiviral vector-based model of Huntington's disease (HD).
A crossover study in neuroimaging and genetics has linked genetic mutations to variations in the size of deep brain structures. This is a new step in evaluating the risk factors for developing a neurodegenerative disease.
Stanislas Dehaene, professor at the Collège de France and a researcher at the CEA-I2BM, has won the “Lire” prize for the best book of the year in the science category, for “Le code de la conscience” (The Code of Consciousness).
An international team involving the CEA-I2BM has just demonstrated that astrocytes induce the neuronal metabolism abnormalities that are characteristic of Huntington’s disease.
Top page
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.